Patents by Inventor Xuejie Yang

Xuejie Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11906662
    Abstract: An electronic device and a method for controlling an electronic device are provided. The electronic device includes a first side and a second side facing away from each other, where a frame is between the first side and the second side; the first side is provided with a display module that is at least partially light-permeable, and a gap is between the display module and the frame; a first light emitting device, a second light emitting device, and a light receiving device are inside the electronic device, the first light emitting device and the light receiving device are below the display module and corresponding to a light-permeable display region of display module, the first light emitting device emits a light signal to the outside through the light-permeable display region, and the second light emitting device emits a light signal to the outside through the gap.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: February 20, 2024
    Assignee: Vivo Mobile Communication Co., Ltd.
    Inventor: Xuejie Yang
  • Patent number: 11269073
    Abstract: An electronic device includes an infrared distance measurement apparatus and a touch panel. The touch panel covers the infrared distance measurement apparatus. The infrared distance measurement apparatus includes an infrared-light-emitting tube and at least two infrared-light-receiving tubes. The at least two infrared-light-receiving tubes include a far-channel receiving tube and a near-channel receiving tube, and a distance between the far-channel receiving tube and the infrared-light-emitting tube is greater than a distance between the near-channel receiving tube and the infrared-light-emitting tube.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: March 8, 2022
    Assignee: VIVO MOBILE COMMUNICATION CO., LTD.
    Inventors: Sheng Li, Xuejie Yang
  • Publication number: 20220026618
    Abstract: An electronic device and a method for controlling an electronic device are provided. The electronic device includes a first side and a second side facing away from each other, where a frame is between the first side and the second side; the first side is provided with a display module that is at least partially light-permeable, and a gap is between the display module and the frame; a first light emitting device, a second light emitting device, and a light receiving device are inside the electronic device, the first light emitting device and the light receiving device are below the display module and corresponding to a light-permeable display region of display module, the first light emitting device emits a light signal to the outside through the light-permeable display region, and the second light emitting device emits a light signal to the outside through the gap.
    Type: Application
    Filed: September 7, 2021
    Publication date: January 27, 2022
    Inventor: Xuejie YANG
  • Publication number: 20190361120
    Abstract: An electronic device includes an infrared distance measurement apparatus and a touch panel. The touch panel covers the infrared distance measurement apparatus. The infrared distance measurement apparatus includes an infrared-light-emitting tube and at least two infrared-light-receiving tubes. The at least two infrared-light-receiving tubes include a far-channel receiving tube and a near-channel receiving tube and a distance between the far-channel receiving tube and the infrared-light-emitting tube is greater than a distance between the near-channel receiving tube and the infrared-light-emitting tube.
    Type: Application
    Filed: December 29, 2017
    Publication date: November 28, 2019
    Applicant: VIVO MOBILE COMMUNICATION CO,. LTD.
    Inventors: Sheng LI, Xuejie YANG
  • Patent number: 8735398
    Abstract: The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein.
    Type: Grant
    Filed: November 7, 2012
    Date of Patent: May 27, 2014
    Assignee: Bristol-Myers Squibb Company
    Inventors: Omar D. Lopez, Denis R. St. Laurent, Jason Goodrich, Jeffrey Lee Romine, Michael Serrano-Wu, Fukang Yang, Ramesh Kakarla, Xuejie Yang, Yuping Qiu, Lawrence B. Snyder
  • Patent number: 8362020
    Abstract: The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: January 29, 2013
    Assignee: Bristol-Myers Squibb Company
    Inventors: Omar D. Lopez, Denis R. St. Laurent, Jason Goodrich, Jeffrey Lee Romine, Michael Serrano-Wu, Fukang Yang, Ramesh Kakarla, Xuejie Yang, Yuping Qiu, Lawrence B. Snyder
  • Patent number: 8143288
    Abstract: Compounds having the structure of formula I are described. The compounds can inhibit hepatitis C virus (HCV) replication, and in particular can inhibit the function of the HCV NS5A protein.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: March 27, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Michael Serrano-Wu, Makonen Belema, Lawrence B. Snyder, Nicholas A. Meanwell, Denis R. St. Laurent, Ramesh Kakarla, Van N. Nguyen, Yuping Qiu, Xuejie Yang, John E. Leet, Min Gao, Donald R. O'Boyle, II, Julie A. Lemm, Fukang Yang
  • Publication number: 20110294819
    Abstract: The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein.
    Type: Application
    Filed: December 21, 2010
    Publication date: December 1, 2011
    Inventors: Omar D. Lopez, Denis R. St. Laurent, Jason Goodrich, Jeffrey Lee Romine, Michael Serrano-Wu, Fukang Yang, Ramesh Kakarla, Xuejie Yang, Yuping Qiu, Lawrence B. Snyder
  • Patent number: 7329668
    Abstract: The present invention provides for pyrazolopurine-based tricyclic compounds having the formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein. The present invention further provides pharmaceutical compositions comprising such compounds, as well as the use of such compounds for treating inflammatory and immune diseases.
    Type: Grant
    Filed: February 24, 2004
    Date of Patent: February 12, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Yuping Qiu, Makonen Belema, Xuejie Yang, Fred Christopher Zusi, William J. Pitts
  • Publication number: 20060276511
    Abstract: Compounds having the structure of formula I are described. The compounds can inhibit hepatitis C virus (HCV) replication, and in particular can inhibit the function of the HCV NS5A protein.
    Type: Application
    Filed: June 5, 2006
    Publication date: December 7, 2006
    Inventors: Michael Serrano-Wu, Makonen Belema, Lawrence Snyder, Nicholas Meanwell, Denis St. Laurent, Ramesh Kakarla, Van Nguyen, Yuping Qiu, Xuejie Yang, John Leet, Min Gao, Donald O'Boyle, Julie Lemm, Fukang Yang
  • Patent number: 6960585
    Abstract: Compounds of formula (I), or pharmaceutically-acceptable salts thereof, are useful in treating inflammatory and immune diseases and disorders, wherein X, Y1, Y2, and R2-4 are as defined in the specification.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: November 1, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Francis Beaulieu, Carl Quellet, Makonen Belema, Yuping Qiu, Xuejie Yang, Fred C. Zusi
  • Patent number: 6933294
    Abstract: Compounds having the formula (I), and pharmaceutically-acceptable salts, hydrates and prodrugs thereof, are useful as anti-inflammatory agents, in which R1, R2, and R3 are hydrogen, halogen, alkyl, or perfluoroalkyl; R4 is an optionally substituted alkyl or cycloalkyl group; X is a linker; A is an aryl, heteroaryl, heterocycle, cycloalkyl, or is absent; and R7 is a substituent on A as defined in the specification.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: August 23, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Makonen Belema, Amy Bunker, Van Nguyen, Francis Beaulieu, Carl Ouellet, Anne Marinier, Stephan Roy, Xuejie Yang, Yuping Qiu, Yunhui Zhang, Alain Martel, Christopher Zusi
  • Publication number: 20040204432
    Abstract: The present invention provides for pyrazolopurine-based tricyclic compounds having the formula (I), 1
    Type: Application
    Filed: February 24, 2004
    Publication date: October 14, 2004
    Inventors: Yuping Qiu, Makonen Belema, Xuejie Yang, Fred Christopher Zusi, William J. Pitts
  • Publication number: 20040058930
    Abstract: Compounds having the formula (I), 1
    Type: Application
    Filed: March 27, 2003
    Publication date: March 25, 2004
    Inventors: Makonen Belema, Amy Bunker, Van Nguyen, Francis Beaulieu, Carl Ouellet, Anne Marinier, Stephan Roy, Xuejie Yang, Yuping Qiu, Yunhui Zhang, Alain Martel, Christopher Zusi
  • Publication number: 20020072523
    Abstract: Compounds of formula (I), or pharmaceutically-acceptable salts thereof, are useful in treating inflammatory and immune diseases and disorders, 1
    Type: Application
    Filed: September 27, 2001
    Publication date: June 13, 2002
    Inventors: Francis Beaulieu, Carl Ouellet, Makonen Belema, Yuping Qiu, Xuejie Yang, Fred C. Zusi